Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026)
Avanos Medical recorded quarterly Income from Continuing Operations of 5100000.0 in Q1 2026, up 492.31% quarter-over-quarter from 1300000.0 in Q4 2025, and down 22.73% year-over-year from 6600000.0 in Q1 2025.
Avanos Medical's Income from Continuing Operations history runs 14 years deep, the most recent figure standing at 5100000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 22.73% year-over-year to 5100000.0; the TTM figure through Mar 2026 stood at 74400000.0 (up 80.43% YoY), while the FY2025 annual figure was 72900000.0, up 81.13% from the prior year.
- Income from Continuing Operations came in at 5100000.0 for Q1 2026 at Avanos Medical, up from 1300000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 11000000.0 in Q3 2022 to a low of 397000000.0 in Q4 2024.
- A 5-year average of 25476470.59 and a median of 4300000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 3709.09% in 2024 and soared 1220.0% in 2025, its largest moves.
- Avanos Medical's Income from Continuing Operations stood at 9700000.0 in 2022, then advanced by 13.4% to 11000000.0 in 2023, then slumped by 3709.09% to 397000000.0 in 2024, then jumped by 99.67% to 1300000.0 in 2025, then soared by 492.31% to 5100000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 5100000.0, 1300000.0, and 1400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -76.80 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | -397.00 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -7.80 Mn |
| Dec 31, 2022 | 9.70 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -25.70 Mn |
| Sep 30, 2021 | -35.30 Mn |
| Jun 30, 2021 | 38.50 Mn |
| Mar 31, 2021 | -8.40 Mn |
| Dec 31, 2020 | -49.00 Mn |
| Sep 30, 2020 | 19.30 Mn |
| Jun 30, 2020 | -3.00 Mn |
| Mar 31, 2020 | 3.70 Mn |
| Dec 31, 2019 | -6.10 Mn |
| Sep 30, 2019 | -11.50 Mn |
| Jun 30, 2019 | -8.00 Mn |
| Mar 31, 2019 | -20.30 Mn |
| Dec 31, 2018 | -2.70 Mn |
| Sep 30, 2018 | 4.20 Mn |
| Jun 30, 2018 | 1.30 Mn |
| Mar 31, 2018 | -11.30 Mn |
| Dec 31, 2017 | 4.40 Mn |
| Sep 30, 2017 | -10.20 Mn |
| Jun 30, 2017 | -11.40 Mn |
| Mar 31, 2017 | -14.90 Mn |
| Dec 31, 2016 | -113.10 Mn |
| Sep 30, 2016 | 9.10 Mn |
| Jun 30, 2016 | 6.50 Mn |
| Mar 31, 2016 | 14.20 Mn |
| Dec 31, 2015 | 339.60 Mn |
| Sep 30, 2015 | -470.50 Mn |
| Jun 30, 2015 | 8.00 Mn |
| Mar 31, 2015 | 21.70 Mn |
| Dec 31, 2014 | -2.40 Mn |
| Sep 30, 2014 | -7.40 Mn |
| Jun 30, 2014 | -4.50 Mn |
| Mar 31, 2014 | 41.40 Mn |
| Dec 31, 2013 | 39.80 Mn |
| Sep 30, 2013 | 47.90 Mn |